Advanced Enzyme Technologies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 30, 2024
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Advanced Enzyme Technologies held its 36th AGM on July 30, 2025, through video conferencing, with 120 members present. Five resolutions were tabled, including adoption of audited standalone and consolidated financial statements for FY25. The Board recommended a final dividend of ₹1.20 per equity share (face value ₹2) for FY ended March 31, 2025. Mr. Mukund Kabra was re-appointed as a Director (retiring by rotation), Mr. Shiv Hari Jalan was appointed as Secretarial Auditor for a five-year term, and shareholders approved related party transactions with subsidiary JC Biotech Private Limited. E-voting ran from July 26 to July 29, 2025, with the Scrutinizer's combined voting results to be submitted to BSE and NSE within the prescribed timeline.
Final dividend of ₹1.20 per share is a modest payout for shareholders and signals steady, profitable operations in FY25. Approval of related party transactions with JC Biotech subsidiary and continuity in Board/Auditor appointments suggest stable governance with no major disruptions expected.